引用次数
引用: 470
H-指数: 14
I10-指数 : 17
出版物: 47
Isoindolinone based inhibitors of the MDM2-p53 protein-protein interaction
SJ Kemp , IR Hardcastle , SU Ahmed , NA Atatreh
Abstracts of Papers of the American Chemical Society
2005
Synthesis of the Novel Difluoro analogue of UCS15A and its Evaluation With Src
J. Barraclough , S Freeman , C Dive , Richard Bryce
In: Contribution to the Bath Medicinal Chemistry Conference; 2006.
2006
Inhibition of Src for potential use in cancer chemotherapy
C Stojkoski , J. Barraclough , G Booker , S Freeman
In: 1st International Conference in Drug Design and Discovery, Dubai; 2008.
2008
Computer aided discovery of inhibitors of thymidine phosphorylase and Src
C Stojkoski , V McNally , A Gbaj , G Booker
In: 1st Workshop of Angiokem; Hannover, Germany. 2007.
2007
PAPERS AND PUBLICATIONS OF ZAYED CENTRE
FA Rihan , DH Abdelrahman , F Al-Maskari , F Ibrahim
Plos One 9 e99163 -e99163
2014
Enzyme adsorption by drug aggregates: probing the molecular basis of inhibitor promiscuity using molecular dynamics simulations
M Ghattas , N Atatreh , S Alrawashdeh , R Bryce
EUROPEAN JOURNAL OF CANCER 103 E68 -E69
2018
Antibacterial activity and mechanism of action of the benzazole acrylonitrile-based compounds
SS AlNeyadi , AA Salem , MA Ghattas , N Atatreh
vitro 270 -282
8
2017
The discovery of potential CDK2-Spy1 inhibitors via structure-based drug design
N Atatreh , M Al Sorkhy , S Al Rawashdah , M Ghattas
EUROPEAN JOURNAL OF CANCER 103 E93 -E94
2018
Design, synthesis and evaluation of inhibitors for Src tyrosine kinase and their impact on colorectal cancer cells
Noor Aldeen SA Atatreh
Manchester University
2007
Virtual screening and in vitro evaluation of non-kinase inhibitors of c-Src-SH3 protein-protein interactions
Cvetan Stojkoski , Sally Freeman , Richard Bryce , Phillippa Smith
Molecular Cancer Therapeutics 6
2007
In silico design of new MPS1 inhibitors via a validated structure-based virtualscreening approach
Mohammad Al Sorkhy , Mohammad A. Ghattas , Noor Atatreh
Der Pharma Chemica 8 ( 2) 365 -374
2016
Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main protease
Mohammad A. Ghattas , Bassam R. Ali , Noor Atatreh , Shaima Hasan
Acta Pharmaceutica 71 ( 3) 325 -333
2021
How Do Small Molecule Aggregates Inhibit Enzyme Activity? A Molecular Dynamics Study
Mohammad A. Ghattas , Sara Al Rawashdeh , Noor Atatreh , Richard A. Bryce
Journal of Chemical Information and Modeling 60 ( 8) 3901 -3909
1
2020
Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds.
Noor Atatreh , Amal M Youssef , Mohammad A Ghattas , Mohammad Al Sorkhy
Bioorganic Chemistry 86 393 -400
11
2019
Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.
Sara Al Rawashdah , Amar Hamrouni , Bassem Sadek , Rawad Amer
Journal of Molecular Graphics & Modelling 92 44 -54
2019
Computer-aided discovery of antimicrobial agents as potential enoyl acyl carrier protein reductase inhibitors
Mohammad A Ghattas , Nermin A Eissa , Sanaa K Bardaweel , Abdallah Abu Mellal
Tropical Journal of Pharmaceutical Research 16 ( 2) 397 -405
2
2017
In silico screening and biological evaluation of inhibitors of Src-SH3 domain interaction with a proline-rich ligand
Noor Atatreh , Cvetan Stojkoski , Phillippa Smith , Grant W. Booker
Bioorganic & Medicinal Chemistry Letters 18 ( 3) 1217 -1222
19
2008
Comparative Molecular Dynamics Simulation of Aggregating and Non-Aggregating Inhibitor Solutions: Understanding the Molecular Basis of Promiscuity.
Mohammad A. Ghattas , Richard A. Bryce , Sara Al Rawashdah , Noor Atatreh
ChemMedChem 13 ( 6) 500 -506
4
2018
Protein tyrosine phosphatases: Ligand interaction analysis and optimisation of virtual screening
Mohammad A. Ghattas , Noor Atatreh , Elena V. Bichenkova , Richard A. Bryce
Journal of Molecular Graphics and Modelling 52 114 -123
9
2014
Druggability analysis and classification of protein tyrosine phosphatase active sites.
Mohammad Ghattas , Noor Raslan , Asil Sadeq , Mohammad Al Sorkhy
Drug Design Development and Therapy 10 3197 -3209
17
2016